Avidity Partners Management LP Ac Immune Sa Transaction History
Avidity Partners Management LP
- $2.03 Billion
- Q2 2024
A detailed history of Avidity Partners Management LP transactions in Ac Immune Sa stock. As of the latest transaction made, Avidity Partners Management LP holds 825,000 shares of ACIU stock, worth $2.48 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
825,000
Previous 4,470,000
81.54%
Holding current value
$2.48 Million
Previous $13.2 Million
75.13%
% of portfolio
0.16%
Previous 0.51%
Shares
12 transactions
Others Institutions Holding ACIU
# of Institutions
46Shares Held
28.3MCall Options Held
163KPut Options Held
37.6K-
Bvf Inc San Francisco, CA18.8MShares$56.5 Million2.3% of portfolio
-
Black Rock Inc. New York, NY2.61MShares$7.82 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA1.81MShares$5.42 Million0.47% of portfolio
-
Wells Fargo & Company San Francisco, CA1.12MShares$3.37 Million0.0% of portfolio
-
Platinum Investment Management LTD Sydney Australia 2000, C3952KShares$2.86 Million0.16% of portfolio
About AC Immune SA
- Ticker ACIU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,413,504
- Market Cap $250M
- Description
- AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...